健康情報回避を減らすための介入
がん情報回避を減らすための介入
Health information avoidance is an overlooked threat to the reach and effectiveness of health communication. To fully realize the benefits of our sizeable investments in health messaging, it is necessary to identify strategies for reducing health information avoidance. The researchers will test a video-based strategy for promoting colorectal cancer screening designed to reduce defensive colorectal cancer information avoidance and increase message reach by increasing engagement among those who would otherwise avoid the message. The researchers will conduct a randomized controlled trial (RCT) comparing the effects of the intervention video to an attentional control video on colorectal cancer screening intentions and uptake.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
The study will test the efficacy and mediating mechanisms of brief video interventions including elements demonstrated to be effective in reducing health information avoidance (self-efficacy boosting, humor, calm affect induction). It is expected that the videos to benefit people who typically avoid health information yet still be beneficial for people who do not avoid health information, thus being suitable for dissemination to general audiences. It is hypothesized that the interventions will strengthen intentions to be screened, increase colorectal cancer risk information seeking and increase screening.
Following recommended practices, the two intervention arms and the control arm will include multiple versions of the videos to control for actor effects. All intervention videos operationalize the same psychological mechanisms but are delivered by 4 different actors and promote either colonoscopy or stool tests. The 8 parallel intervention and 4 control videos will be treated as random effects.
The intervention videos will be tested in members of the Ipsos panel who are not adherent to colorectal cancer screening guidelines, half of whom will be selected because they tend to avoid colorectal cancer information. Effects of the intervention videos will be compared to those of an attentional control video about food safety.
研究の種類
研究の種類
入学 (実際)
入学
段階
段階
- 適用できない
連絡先と場所
研究場所
-
-
New York
-
Buffalo、New York、アメリカ、14222
- University at Buffalo
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- between the ages of 45 and 75 years
- never diagnosed with colorectal cancer
- non-adherent to colorectal cancer screening guidelines
- half will have a score at or greater than the mid-point on the colorectal cancer information avoidance scale (≥2.5) on the pre-screening survey such that half of the sample are people who tend to avoid colorectal cancer information
Exclusion Criteria:
- not between the ages of 45 and 75 years
- have been diagnosed with colorectal cancer
- adherent to colorectal cancer screening guidelines
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:ダブル
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Video to promote colonoscopy
Participants will view a brief video promoting colonoscopy with self-efficacy enhancement, humor and calm affect induction |
This video contains elements designed to engage and persuade people who tend to avoid colorectal cancer information to have a colonoscopy. Psychological elements include self-efficacy boosting, humor, and calming affect induction. |
|
実験的:Video to promote screening for colorectal cancer with home tests
Participants will view a brief video promoting colorectal cancer home testing with self-efficacy enhancement, humor and calm affect induction |
This video contains elements designed to engage and persuade people who tend to avoid colorectal cancer information to screen for colorectal cancer with a home test. Psychological elements include self-efficacy boosting, humor, and calming affect induction. |
|
介入なし:Attentional control video
The attentional control video will be about food safety and will be the same length and include the same actors and music. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Strength of screening intentions
時間枠:Day 1
|
Participants will rate their intention to be screened with the item, "I intend to get checked for colon cancer within the next 6 months" on a scale from 1 to 4 with 4 being stronger intentions. |
Day 1
|
|
Strength of intentions to talk to a health care provider about being screened for colorectal cancer
時間枠:Day 1
|
This outcome will be assessed with the item, "I will talk to a health care provider about getting checked for colon cancer within the next 6 months". |
Day 1
|
|
Proportion of participants who seek personal risk information
時間枠:Day 1
|
Participants will be asked whether they want to be redirected at the end of the study to complete the online Siteman Cancer Center colorectal cancer risk calculator. |
Day 1
|
|
Proportion of participants screened for colorectal cancer after 9 months
時間枠:At least 9 months after start of study
|
The researchers will assess whether participants have been screened for colorectal cancer in the 9 months since participating in the intervention phase of the study. |
At least 9 months after start of study
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Self-efficacy for colorectal cancer screening
時間枠:Day 1
|
Sel-efficacy will be assessed with 2 items with which participants rate their confidence in arranging to get screened and completing a screening test on a scale ranging from 0 to 10, with 10 indicating greater self-efficacy. |
Day 1
|
|
Positive and negative affect
時間枠:Day 1
|
Positive and negative affect will be assessed with the Positive and Negative Affect Schedule Short Form (PANAS-SF). Scores range from 1 to 5, with higher scores indicating more of a given affect. |
Day 1
|
協力者と研究者
協力者
協力者
捜査官
捜査官
- 主任研究者:Heather Orom Associate Professor, PhD、University at Buffalo
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (実際)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
その他の研究ID番号
- STUDY00009059
- R01CA276430 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
All non-identifying study data will be shared.
IPD 共有時間枠
IPD will be available once results are published. There will be no end date.
IPD 共有アクセス基準
Anyone will be able to access the IDP through OSF.
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- ANALYTIC_CODE
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。